Related Experiment Video
Updated: Apr 6, 2026

A Novel Approach to Monitoring Graft Neovascularization in the Human Gingiva
Published on: January 12, 2019
Ca-channel blocker-induced gingival overgrowth that improved with non-surgical therapy during visiting care: a case
Tomotaka Kato1, Hiroya Takiuchi1, Masahiro Yamaguchi1
1Section of Geriatric Dentistry, Department of General Dentistry, Fukuoka Dental College, Fukuoka city, Japan.
Objectives:
To present a case of gingival overgrowth during visiting care.
Background:
Ca-channel blocker-induced gingival overgrowth is a well-known adverse event. However, only limited information on the treatment of calcium-channel blocker-induced gingival overgrowth during visiting care has been reported.
Clinical Report:
The patient was an 88-year-old female living in a nursing home since dementia. She had been taking a calcium-channel blocker and observed gingival overgrowth. Initial therapy was performed and changed the antihypertensive medication from a calcium-channel blocker to an angiotensin converting enzyme inhibitor. After initial therapy, the gingival overgrowth improved significantly. In addition, the defecation rate was improved.
Conclusion:
This case indicated that periodontal therapy is useful even for dementia patients during visiting dental care.
Related Concept Videos
Tonsillitis II: Management
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
